glutathione s transferase inhibitors Unveiling the Role of S-transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione transferases as mediators of

Cagrilintide target doses in the combination The optimal cagrilintide dose in the combination context appears to be between 1.0 mg and 2.4 mg weekly based on available data

The results revealed that Fer-1 effectively ameliorated SiO 2 -induced lung ventilation impairments, including both restrictive and obstructive ventilation disorders

Too much glutamate left in the synapse could cause excess activation of the glutamate receptors

Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy

Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii